<< Scientists are a step closer to developing drug targets to treat fungal meningitis | Anti-seizure drugs slow aging in roundworms >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Researchers have identified the cellular receptor for the JC virus

Published on January 17, 2005 at 5:03 AM · No Comments

Researchers funded in part by the National Institute of Neurological Disorders and Stroke (NINDS) have identified the cellular receptor for the JC virus, which causes the fatal neurological disease progressive multifocal leukoencephalopathy (PML).

Generic medicines currently available may be useful in preventing the infection. Findings appeared in the November 19, 2004 issue of Science.

Walter Atwood, Ph.D., professor of biology and medicine at Brown University, and colleagues hoped to identify the way the JC virus enters the cell and learn how to prevent its transmission into the nervous system. They first tested the drug chlorpromazine and found it was able to effectively block viral transmission to glial cells—non-nerve cells in the brain that support and protect its function. This drug, however, which is used to treat psychosis, can cause severe side effects. The scientists then tested the related compound clozapine, which produces less adverse effects, and found that it also blocked viral transmission. Since both drugs belong to a class of drugs known as serotonin-dopamine inhibitors, the research team hypothesized that the JC virus may use either serotonin receptors or dopamine receptors to infect glial cells.

By testing similar compounds, the scientists learned that the JC virus enters the central nervous system by fastening itself to the 5HT2AR receptor for serotonin, which is found on the surface of glial cells. When this receptor for serotonin is triggered, it opens the pathway that allows the virus to enter the cell.

To verify this finding, the team tried but failed to transmit the JC virus to cancer cells that don’t contain the protein that signals 5HT2AR. The team then genetically modified the cancer cells to express 5HT2AR and found the altered cells could be infected by the virus.

“This is a very exciting finding because it increases our understanding of the basic biology of JC virus infection and at the same time opens the door to possible therapeutic intervention of PML using existing drugs that do not harm nervous system function,” said Dr. Atwood.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading